(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-First...ouncedthatithasreceivednoticefrom,theNasdaqStockMa...pendedasofNovember30,2009andaForm25-NSEwillbefiled...emovedeCODE,scommonstock,fromlistingonNasdaq,unles...cationsPanel.Thecompanyhasfiledsuchanappeal,which,...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-First...ouncedtheapprovalofallofits,"firstday"motionsbythe...ankruptcyCourt").deCODElastweekfiledavoluntarypeti...uptcyCodewiththe,BankruptcyCourt. , Theorders...e,tooperateitsbusinessduringtheChapter11proceeding...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBio...ration(SFDA)hasapprovedthe,investigationalnewdruga...ninnovativeinsulinformulationtotreatdiabetes.ThisI...inicalstudy. , Diabetesisadisordercharacteris...ationsofdiabetesoftenresultinseveremicro-and,macro...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4..., March 5 NeoStem, Inc. (Amex: NBS ),which is pi...d long-term,storage of adult stem cells for future...n, Ph.D., NeoStem,s Director of Stem Cell Science ... campus this evening. In,October 2007, NeoStem ann...cell collection centers into Las Vegas, the first ...
...N, N.J., March 5 Novo Nordisk, a,healthcare compa...vement in,diabetes care, today announced plans to ...modate future growth. In the past five years, the ...employees at its U.S.,headquarters., The new buil...oyees and,feature an in-house training facility ca...
...PHIA, March 5 Cellvizio Inc., a leader in in,vivo...live U.S.,demonstration of its Cellvizio(R) GI tec...e Johns Hopkins University School of Medicine,s Ei...a Vida Conference., Cellvizio Inc. is the U.S. su... develops and markets Cellvizio, a fundamentally n...
Other Biology Technology:NeoStem's Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus 2NeoStem's Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus 3Novo Nordisk Expands U.S. Headquarters in New Jersey 2Novo Nordisk Expands U.S. Headquarters in New Jersey 3First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference 2Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Biology Products: